Impact of Medical Emergency Team in Tampere University Hospital

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jyrki Tenhunen, Tampere University Hospital
ClinicalTrials.gov Identifier:
NCT01214460
First received: July 5, 2010
Last updated: January 22, 2014
Last verified: January 2014
  Purpose

Patients in general wards have abnormal physical values preceding in-hospital cardiac arrest or a transfer to intensive care unit (ICU). The purpose of Medical Emergency Team (MET)is to interfere early enough in deteriorating patient status to prevent adverse outcomes like cardiac arrest or transfer to intensive care unit. The aims of this study are to record and analyze the effects of both afferent and efferent limbs of MET activity in Finnish tertiary Hospital.


Condition
Sudden In-hospital Cardiac Arrest

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact of Medical Emergency Team on ICU Readmissions and Sudden Cardiac Arrests in Tampere University Hospital

Resource links provided by NLM:


Further study details as provided by Tampere University Hospital:

Primary Outcome Measures:
  • The number of patients medical emergency team is called to treat in TAUH [ Time Frame: One year ] [ Designated as safety issue: No ]
    We are going to analyze the number of MET calls and their impact on sudden cardiac arrests in TAUH. The time frame is 1st Jan 2010 -31st Dec 2010. It is known fact that well working MET team inside the hospital should decrease the sudden cardiac arrests.

  • The number of sudden cardiac arrests in TAUH [ Time Frame: One year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The rates of ICU readmissions [ Time Frame: One year ] [ Designated as safety issue: No ]
  • The rates of DNAR orders [ Time Frame: one year ] [ Designated as safety issue: No ]
  • In-hospital mortality [ Time Frame: patients are followed until death ] [ Designated as safety issue: No ]
  • Patient mortality after 6 mo of discharge [ Time Frame: Six mo ] [ Designated as safety issue: No ]
    The patients are followed 6 mo after hospital discharge which has happened in year 2010


Enrollment: 1000
Study Start Date: January 2010
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
All MET calls

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All adult in-hospital patients with deteriorating vital signs or patients in risk in Tampere University Hospital

Criteria

Inclusion Criteria:

  • 18 yrs or older

Exclusion Criteria:

  • under 18 yrs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01214460

Locations
Finland
Critical Care Medicine Research Group, Tampere University Hospital
Tampere, Pirkanmaa, Finland, 33521
Sponsors and Collaborators
Tampere University Hospital
Investigators
Study Director: Jyrki Tenhunen, MD, PhD Critical Care Medicine Research Group
Principal Investigator: Sanna Hoppu, MD, PhD Critical Care Medicine Research Group
Principal Investigator: Joonas Tirkkonen, MB Critical Care Medicine Research Group
  More Information

No publications provided

Responsible Party: Jyrki Tenhunen, Researcher, Tampere University Hospital
ClinicalTrials.gov Identifier: NCT01214460     History of Changes
Other Study ID Numbers: R10111
Study First Received: July 5, 2010
Last Updated: January 22, 2014
Health Authority: Finland: Ethics Committee

Keywords provided by Tampere University Hospital:
MET

Additional relevant MeSH terms:
Emergencies
Heart Arrest
Death, Sudden, Cardiac
Disease Attributes
Pathologic Processes
Heart Diseases
Cardiovascular Diseases
Death, Sudden
Death

ClinicalTrials.gov processed this record on July 23, 2014